Vigil Neuroscience, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vigil Neuroscience, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q3 2024.
  • Vigil Neuroscience, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.54M, a 4.74% increase year-over-year.
  • Vigil Neuroscience, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $10M, a 26.8% increase year-over-year.
  • Vigil Neuroscience, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $8.9M, a 62.6% increase from 2022.
  • Vigil Neuroscience, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.48M, a 163% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $10M $2.54M +$115K +4.74% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $9.93M $2.7M +$447K +19.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $9.48M $2.31M +$578K +33.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $8.9M $2.49M +$985K +65.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $7.92M $2.43M +$932K +62.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $6.99M $2.26M +$796K +54.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $6.19M $1.73M +$713K +69.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $5.48M $1.5M +$739K +97% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $4.74M $1.49M +$938K +169% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $3.8M $1.46M +$1.03M +237% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $2.77M $1.02M +$688K +207% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $2.09M $762K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-21
Q3 2021 $556K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $434K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $333K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.